The global synthetic biology market is poised for significant growth, with an expected value of USD 52.6 billion by the year 2030. According to recent market analysis, the market size for synthetic biology was estimated at USD 13.1 billion in 2022, indicating a robust upward trajectory with a Compound Annual Growth Rate (CAGR) of 19.0% during the forecast period from 2023 to 2030.
Synthetic biology, an interdisciplinary field combining biology, engineering, and computational sciences, enables the design, construction, and optimization of biological systems for diverse applications, including healthcare, agriculture, industrial biotechnology, and environmental sustainability. Key factors driving the growth of the synthetic biology market include:
Advancements in Genetic Engineering and Gene Editing Technologies: Continuous advancements in genetic engineering tools, gene editing techniques, and DNA synthesis platforms, including CRISPR-Cas9, gene synthesis, and directed evolution, are driving innovation in synthetic biology applications, enabling rapid prototyping and optimization of biological systems.
Expanding Applications in Healthcare and Biopharmaceuticals: The increasing adoption of synthetic biology in healthcare and biopharmaceutical research for drug discovery, biomanufacturing, and personalized medicine approaches is driving market growth and investment in therapeutic applications, including gene therapies, cell-based therapies, and therapeutic proteins production.
Industrial Biotechnology and Bio-based Manufacturing: The growing demand for sustainable bio-based products, renewable chemicals, and biofuels is driving investment in industrial biotechnology and synthetic biology platforms for metabolic engineering, enzyme optimization, and microbial fermentation, enabling the production of bio-based alternatives to traditional chemicals and fuels.
AgriTech and Genetic Crop Improvement: The application of synthetic biology in AgriTech and agricultural biotechnology for crop improvement, trait engineering, and agricultural sustainability initiatives is driving market growth and adoption of synthetic biology tools for precision agriculture, crop protection, and genetic crop enhancement.
Bioinformatics and Computational Modeling: The integration of bioinformatics, computational modeling, and systems biology approaches in synthetic biology design and optimization is driving advancements in predictive modeling, pathway engineering, and genome-scale design, enhancing design predictability and accelerating development timelines.
Regulatory Support and Industry Collaboration: Supportive regulatory frameworks, industry collaborations, and public-private partnerships promoting innovation in synthetic biology research, development, and commercialization are driving market growth and fostering collaboration across academia, government, and industry stakeholders.
KEY MARKET SEGMENTATION
By Technology
- NGS Technology
- PCR Technology
- Genome Editing Technology
- Bioprocessing Technology
- Other Technologies
By Product
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
By Application
- Healthcare
- Clinical
- Non-Clinical
- Non-healthcare
- Biotech Crops
- Specialty Chemicals
- Bio-fuels
- Others
By End User
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Others
The major key players are Bota Biosciences Inc., Codexis, Inc., Creative Biogene., Creative Enzymes., Enbiotix, Inc., Illumina, Inc., Merck Kgaa (Sigma-Aldrich Co. Llc), New England Biolabs, Euro fins Scientific, Novozymes, Pareto Bio, Inc., Synthetic Genomics Inc., Thermo Fisher Scientific, Inc., and Others.
As the global bioeconomy continues to expand, driven by sustainability goals, technological innovation, and healthcare advancements, the synthetic biology market is expected to witness sustained growth, driven by increasing demand for bio-based solutions, personalized therapeutics, and sustainable biomanufacturing processes.
Other Reports You May Like:
Orthopedic Devices Market Growth
Pharmacy Benefit Management Market Growth
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com